ARTAÇ, M. Et Al. 2019. Bevacuzimab May Be Less Effective in Obese Metastatic Colorectal Cancer Patients. JOURNAL OF GASTROINTESTINAL CANCER , vol.50, no.2 , 214-220.

ARTAÇ, M., Korkmaz, L., COŞKUN, H. Ş., Dane, F., KARABULUT, B., KARAAĞAÇ, M., ... ÇABUK, D.(2019). Bevacuzimab May Be Less Effective in Obese Metastatic Colorectal Cancer Patients. JOURNAL OF GASTROINTESTINAL CANCER , vol.50, no.2, 214-220.

ARTAÇ, MEHMET Et Al. "Bevacuzimab May Be Less Effective in Obese Metastatic Colorectal Cancer Patients," JOURNAL OF GASTROINTESTINAL CANCER , vol.50, no.2, 214-220, 2019

ARTAÇ, MEHMET Et Al. "Bevacuzimab May Be Less Effective in Obese Metastatic Colorectal Cancer Patients." JOURNAL OF GASTROINTESTINAL CANCER , vol.50, no.2, pp.214-220, 2019

ARTAÇ, M. Et Al. (2019) . "Bevacuzimab May Be Less Effective in Obese Metastatic Colorectal Cancer Patients." JOURNAL OF GASTROINTESTINAL CANCER , vol.50, no.2, pp.214-220.

@article{article, author={MEHMET ARTAÇ Et Al. }, title={Bevacuzimab May Be Less Effective in Obese Metastatic Colorectal Cancer Patients}, journal={JOURNAL OF GASTROINTESTINAL CANCER}, year=2019, pages={214-220} }